Chang Y, Brewer NT, Rinas AC, Schmitt K, Smith JS (Julho de 2009). «Evaluating the impact of human papillomavirus vaccines». Vaccine. 27 (32): 4355–62. PMID19515467. doi:10.1016/j.vaccine.2009.03.008
Liesegang TJ (Agosto de 2009). «Varicella zoster virus vaccines: effective, but concerns linger». Can. J. Ophthalmol. 44 (4): 379–84. PMID19606157. doi:10.3129/i09-126
Liesegang TJ (Agosto de 2009). «Varicella zoster virus vaccines: effective, but concerns linger». Can. J. Ophthalmol. 44 (4): 379–84. PMID19606157. doi:10.3129/i09-126
Van Sant JE (2008). «The Vaccinators: Smallpox, Medical Knowledge, and the 'Opening' of Japan». J Hist Med Allied Sci. 63 (2): 276–9. doi:10.1093/jhmas/jrn014
Baarda, Benjamin I.; Sikora, Aleksandra E. (2015). «Proteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old disease». Frontiers in Microbiology. 6. ISSN1664-302X. doi:10.3389/fmicb.2015.01190; Access provided by the Universidade de Pittsburgh.
Grammatikos, Alexandros P.; Mantadakis, Elpis; Falagas, Matthew E. (junho de 2009). «Meta-analyses on Pediatric Infections and Vaccines». Infectious Disease Clinics of North America. 23 (2): 431–57. PMID19393917. doi:10.1016/j.idc.2009.01.008
Anguille, S; Smits, EL; Lion, E; van Tendeloo, VF; Berneman, ZN (junho de 2014). «Clinical use of dendritic cells for cancer therapy.». The Lancet. Oncology. 15 (7): e257-67. PMID24872109. doi:10.1016/s1470-2045(13)70585-0
Bae K, Choi J, Jang Y, Ahn S, Hur B (2009). «Innovative vaccine production technologies: the evolution and value of vaccine production technologies». Arch Pharm Res. 32 (4): 465–80. PMID19407962. doi:10.1007/s12272-009-1400-1
Meade T (1989). «'Living worse and costing more': resistance and riot in Rio de Janeiro, 1890–1917». J Lat Am Stud. 21 (2): 241–66. doi:10.1017/S0022216X00014784
Chang Y, Brewer NT, Rinas AC, Schmitt K, Smith JS (Julho de 2009). «Evaluating the impact of human papillomavirus vaccines». Vaccine. 27 (32): 4355–62. PMID19515467. doi:10.1016/j.vaccine.2009.03.008
Liesegang TJ (Agosto de 2009). «Varicella zoster virus vaccines: effective, but concerns linger». Can. J. Ophthalmol. 44 (4): 379–84. PMID19606157. doi:10.3129/i09-126
Liesegang TJ (Agosto de 2009). «Varicella zoster virus vaccines: effective, but concerns linger». Can. J. Ophthalmol. 44 (4): 379–84. PMID19606157. doi:10.3129/i09-126
Grammatikos, Alexandros P.; Mantadakis, Elpis; Falagas, Matthew E. (junho de 2009). «Meta-analyses on Pediatric Infections and Vaccines». Infectious Disease Clinics of North America. 23 (2): 431–57. PMID19393917. doi:10.1016/j.idc.2009.01.008
Anguille, S; Smits, EL; Lion, E; van Tendeloo, VF; Berneman, ZN (junho de 2014). «Clinical use of dendritic cells for cancer therapy.». The Lancet. Oncology. 15 (7): e257-67. PMID24872109. doi:10.1016/s1470-2045(13)70585-0
Bae K, Choi J, Jang Y, Ahn S, Hur B (2009). «Innovative vaccine production technologies: the evolution and value of vaccine production technologies». Arch Pharm Res. 32 (4): 465–80. PMID19407962. doi:10.1007/s12272-009-1400-1
Elizabeth Halloran e Claudio J. Struchiner (ed.). «Avaliação dos efeitos de vacinas»(PDF). Scielo Books. Consultado em 22 de maio de 2017
sciencedirect.com
Rein Verbeke, Ine Lentacker, Stefaan C. De Smedt, Heleen Dewitte (outubro de 2019). «Three decades of messenger RNA vaccine development». sciencedirect.com (em inglês). Consultado em 11 de outubro de 2024 !CS1 manut: Nomes múltiplos: lista de autores (link)
Megan A. McNamara, Smita K. Nair, Eda K. Holl (19 de novembro de 2015). «RNA-Based Vaccines in Cancer Immunotherapy». onlinelibrary.wiley.com. Journal of Immunology Research. Consultado em 11 de outubro de 2024 !CS1 manut: Nomes múltiplos: lista de autores (link)
worldcat.org
Baarda, Benjamin I.; Sikora, Aleksandra E. (2015). «Proteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old disease». Frontiers in Microbiology. 6. ISSN1664-302X. doi:10.3389/fmicb.2015.01190; Access provided by the Universidade de Pittsburgh.